Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition Corp II is a special purpose acquisition company established to identify and execute a business combination with an operating company in the pharmaceutical sector, with particular focus on domestic manufacturing and supply chain resilience. The company targets the acquisition and integration of a platform pharmaceutical business capable of end-to-end production—from plant-based raw material sourcing and active pharmaceutical ingredient production through drug manufacturing and distribution—to address documented U.S. supply chain vulnerabilities and create a domestically-based producer with advanced manufacturing capabilities. The company generates returns through a successful business combination and the subsequent value creation of the combined enterprise, leveraging the management team's extensive pharmaceutical industry expertise and relationships.